| Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma (NCT00334282) | GlaxoSmithKline | 2006-04-01 |
| Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients (NCT00358488) | GlaxoSmithKline | 2006-04-01 |
| Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants (NCT00320463) | GlaxoSmithKline | 2006-04-01 |
| Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria (NCT00371735) | GlaxoSmithKline | 2006-04-01 |
| Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day) (NCT01371474) | GlaxoSmithKline | 2006-04-01 |
| GW823093C For The Treatment Of Type 2 Diabetes Mellitus (NCT00370942) | GlaxoSmithKline | 2006-04-01 |
| Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ (NCT00352898) | GlaxoSmithKline | 2006-04-01 |
| A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole (NCT00422994) | GlaxoSmithKline | 2006-04-01 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. (NCT00338351) | GlaxoSmithKline | 2006-04-01 |
| Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age (NCT00309647) | GlaxoSmithKline | 2006-03-29 |
| Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years (NCT00309634) | GlaxoSmithKline | 2006-03-27 |
| Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects (NCT00406003) | GlaxoSmithKline | 2006-03-24 |
| Study Of GW823093 In Japanese Subjects With Type 2 Diabetes Mellitus (NCT00372957) | GlaxoSmithKline | 2006-03-22 |
| Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00379730) | GlaxoSmithKline | 2006-03-21 |
| A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer (NCT00281632) | GlaxoSmithKline | 2006-03-01 |
| Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ (NCT00353288) | GlaxoSmithKline | 2006-03-01 |
| Chronic Obstructive Pulmonary Disease Endpoints Study (NCT00358358) | GlaxoSmithKline | 2006-03-01 |
| Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women (NCT00326248) | GlaxoSmithKline | 2006-03-01 |
| Long-term Study Of Ropinirole In Restless Legs Syndrome (NCT00329602) | GlaxoSmithKline | 2006-03-01 |
| Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™ (NCT00306982) | GlaxoSmithKline | 2006-03-01 |
| A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention (NCT00291902) | GlaxoSmithKline | 2006-03-01 |
| A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer (NCT00371566) | GlaxoSmithKline | 2006-03-01 |
| Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber (NCT00377728) | GlaxoSmithKline | 2006-03-01 |
| A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years (NCT00306241) | GlaxoSmithKline | 2006-03-01 |
| Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women (NCT00334152) | GlaxoSmithKline | 2006-03-01 |
| A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ (NCT00891293) | GlaxoSmithKline | 2006-03-01 |
| Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes (NCT00351923) | GlaxoSmithKline | 2006-03-01 |
| Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis (NCT00354510) | GlaxoSmithKline | 2006-03-01 |
| Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine (NCT00297856) | GlaxoSmithKline | 2006-03-01 |
| Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age. (NCT00316680) | GlaxoSmithKline | 2006-03-01 |
| Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine (NCT00289783) | GlaxoSmithKline | 2006-02-22 |
| VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 (NCT00306293) | GlaxoSmithKline | 2006-02-20 |
| Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects (NCT00331058) | GlaxoSmithKline | 2006-02-18 |
| Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects (NCT00368979) | GlaxoSmithKline | 2006-02-17 |
| Hip Fracture Study of GSK576428 (Fondaparinux Sodium) (NCT00320424) | GlaxoSmithKline | 2006-02-16 |
| Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older (NCT00294047) | GlaxoSmithKline | 2006-02-16 |
| Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India (NCT00289172) | GlaxoSmithKline | 2006-02-10 |
| Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) (NCT00289198) | GlaxoSmithKline | 2006-02-07 |
| The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics (NCT00453791) | GlaxoSmithKline | 2006-02-07 |
| Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants (NCT00197275) | GlaxoSmithKline | 2006-02-01 |
| RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole (NCT00314860) | GlaxoSmithKline | 2006-02-01 |
| In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus (NCT00354536) | GlaxoSmithKline | 2006-02-01 |
| Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study (NCT00291343) | GlaxoSmithKline | 2006-02-01 |
| Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) (NCT00320398) | GlaxoSmithKline | 2006-01-30 |
| US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease (NCT00282295) | GlaxoSmithKline | 2006-01-25 |
| Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m (NCT00136604) | GlaxoSmithKline | 2006-01-22 |
| Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors (NCT00296517) | GlaxoSmithKline | 2006-01-19 |
| Pharmacokinetic Profiles Of Amoxicillin 2000 mg And Clavulanate 125 mg In Adolescent Patients (NCT00354965) | GlaxoSmithKline | 2006-01-19 |
| Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years (NCT00290329) | GlaxoSmithKline | 2006-01-14 |
| BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy- (NCT00297063) | GlaxoSmithKline | 2006-01-11 |
| COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension (NCT00273052) | GlaxoSmithKline | 2006-01-05 |
| Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants (NCT00290342) | GlaxoSmithKline | 2006-01-01 |
| Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin (NCT00269061) | GlaxoSmithKline | 2006-01-01 |
| fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder (NCT00332046) | GlaxoSmithKline | 2006-01-01 |
| Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia (NCT00280423) | GlaxoSmithKline | 2006-01-01 |
| Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule (NCT00307034) | GlaxoSmithKline | 2006-01-01 |
| Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients (NCT00316719) | GlaxoSmithKline | 2006-01-01 |
| Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia (NCT00280436) | GlaxoSmithKline | 2006-01-01 |
| GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients (NCT00291356) | GlaxoSmithKline | 2006-01-01 |
| Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks (NCT00297180) | GlaxoSmithKline | 2006-01-01 |
| A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days. (NCT00379990) | GlaxoSmithKline | 2006-01-01 |
| Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B (NCT00324961) | GlaxoSmithKline | 2006-01-01 |
| Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients (NCT00332319) | GlaxoSmithKline | 2006-01-01 |
| Clinical Study Of Migraine Evolution (NCT00460005) | GlaxoSmithKline | 2006-01-01 |
| An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia (NCT00358410) | GlaxoSmithKline | 2006-01-01 |
| Use Of SB-705498 In The Acute Treatment Of Migraine (NCT00269022) | GlaxoSmithKline | 2006-01-01 |
| Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease (NCT00279019) | GlaxoSmithKline | 2005-12-12 |
| SB-705498 Dental Pain Study After Tooth Extraction (NCT00281684) | GlaxoSmithKline | 2005-12-07 |
| SERETIDE Plus Tiotropium Versus Individual Components (NCT00325169) | GlaxoSmithKline | 2005-12-01 |
| Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment (NCT00359177) | GlaxoSmithKline | 2005-12-01 |
| An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients (NCT00274703) | GlaxoSmithKline | 2005-12-01 |
| An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine (NCT00319137) | GlaxoSmithKline | 2005-12-01 |
| Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy (NCT00235755) | GlaxoSmithKline | 2005-12-01 |
| A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder (NCT00321477) | GlaxoSmithKline | 2005-12-01 |
| Social Anxiety Disorder Study Of Paroxetine (NCT00318669) | GlaxoSmithKline | 2005-12-01 |
| Study In Patients With Dyslipidaemia (NCT00264667) | GlaxoSmithKline | 2005-12-01 |
| Effect Of GW501516X On How The Heart Obtains And Uses Energy (NCT00318617) | GlaxoSmithKline | 2005-12-01 |
| Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules (NCT00316147) | GlaxoSmithKline | 2005-12-01 |
| Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints (NCT00292552) | GlaxoSmithKline | 2005-12-01 |
| GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer (NCT00320411) | GlaxoSmithKline | 2005-11-28 |
| A First Time In Human Study To Assess The Compound GSK615915 (NCT00400660) | GlaxoSmithKline | 2005-11-23 |
| To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients (NCT00258050) | GlaxoSmithKline | 2005-11-21 |
| Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids (NCT00353873) | GlaxoSmithKline | 2005-11-18 |
| Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years (NCT00372255) | GlaxoSmithKline | 2005-11-17 |
| Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects (NCT00903409) | GlaxoSmithKline | 2005-11-15 |
| Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) (NCT00256854) | GlaxoSmithKline | 2005-11-14 |
| Integrated Biomarker And Imaging Study - 2 (NCT00268996) | GlaxoSmithKline | 2005-11-10 |
| The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients (NCT00338338) | GlaxoSmithKline | 2005-11-07 |
| Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects (NCT00244751) | GlaxoSmithKline | 2005-11-02 |
| Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00259909) | GlaxoSmithKline | 2005-11-02 |
| Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product (NCT00291382) | GlaxoSmithKline | 2005-11-01 |
| A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (NCT00523913) | GlaxoSmithKline | 2005-11-01 |
| Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke (NCT00240643) | GlaxoSmithKline | 2005-11-01 |
| 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes (NCT00318656) | GlaxoSmithKline | 2005-11-01 |
| Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic Subjects (NCT00246701) | GlaxoSmithKline | 2005-11-01 |
| SB-681323 In Subjects With Rheumatoid Arthritis (NCT00320450) | GlaxoSmithKline | 2005-11-01 |
| A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study (NCT00307554) | GlaxoSmithKline | 2005-11-01 |
| Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA) (NCT00256919) | GlaxoSmithKline | 2005-11-01 |
| Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma (NCT00297258) | GlaxoSmithKline | 2005-11-01 |
| SB-480848 In Subjects With Coronary Heart Disease (NCT00269048) | GlaxoSmithKline | 2005-11-01 |